Epicore Bionetworks Inc. V.EBN

Q118

[rationalexuberance]

Another strong quarter.  Revs up 14.5%.  Earnings of 2.0 cents Cdn.  21 cents of cash.

Just makes it hurt even more that this company is being sold at such a low valuation.

[nilyab]

I think that there is a penalty to pay if they sell the company to anyone else at this point. However, maybe some buyer will want to step in with a higher price that includes payment of the penalty. But, I think that's unlikely.

[4frankly]

vote no

[rationalexuberance]

The $1.42mil penalty equates to only 5.3 cents, so it would cost a competiing suitor only $1.35 plus a premium to shareholders to acquire EBN, which is still ridiculously cheap at only a p/e of 14 after cash is subtacted. Voting "no" makes a lot of sense, especially considering Neovia probably owns a whack of shares and would be forced to sweeten the bid if it perceives or if it doesn

[Barley1]

I agree with you, but a large, very large, number of shares are in the hands of a very small group of people, and they want out! I don't think there's really much chance of either a "No"vote or a competitive bid. I n my personal opinion the Company is being given away far too cheaply.